
Jan 12 (Reuters) - Medtronic has "significant firepower" to pursue acquisitions as the medical device maker evaluates opportunities to expand its portfolio, executives said at a major industry conference that kicked off on Monday in San Francisco.
The medical device maker has been eyeing tuck-in deals as it seeks to diversify its portfolio, particularly in cardiology and neuroscience, with CEO Geoff Martha in November saying that they would prefer companies in "early stage or close to market."
The company's balance sheet gives it flexibility to execute a "meaningful number" of transactions without financial strain, Chief Financial Officer Thierry Piéton said at the J.P. Morgan healthcare conference on Monday.
"What's changing versus the last few years is coming back to doing more M&A," he said, adding that Medtronic's dividend policy remains unchanged.
Medtronic, which makes devices ranging from pacemakers to insulin pumps, reported a 3.7% rise in revenue to $33.6 billion in fiscal 2025.
The company is targeting deals in the low- to mid-single-digit billions of dollars, choosing targets that will supplement its internal R&D efforts, Martha said on Monday. The company has set up a new committee at the board level to move faster on deals, he added.
The executives said Medtronic is focused on two themes, expanding in areas where it already competes and acquiring enabling technologies for procedures such as cardiac ablation and surgical robotics.
The company has spent recent years improving operations by divesting non-core units and plans to spin off its diabetes business as MiniMed Group through a U.S. initial public offering following its struggles over the last few years.
It also added two new directors to its board last year after activist investor Elliott Investment Management emerged as one of its largest shareholders.
Medtronic now sees itself positioned to pursue strategic opportunities.
"We've earned the right to do these acquisition, and we've got the capacity, so we're going to step up," Piéton said.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Alan Barona and Leroy Leo)
latest_posts
- 1
Impact of NIH funding reductions felt in cancer and infectious disease trials - 2
Cyber Monday 2025 streaming deal: Get $42 off six months of Apple TV - 3
Israeli archaeologists launch project to trace origins of ancient pottery - 4
Is 'Stranger Things' releasing one last episode? The 'Conformity Gate' fan theory explained as speculation mounts. - 5
German foreign minister heads to China to talk rare-earth exports
Bestselling author Colleen Hoover reveals cancer journey
Jamie Dimon warns Iran war could drive inflation, interest rates higher
Advocacy groups react after Mattel introduces 1st Barbie doll with autism
Distributed storage Answers for Information Reinforcement
Merz postpones Norway trip for Belgium talks on frozen Russian assets
Figure out How to Amplify Innovation and Infotainment Frameworks for Senior Drivers in SUVs
Common ADHD medication prescribed in childhood may protect against risk of psychosis
4 astronauts are en route home from ISS after medical issue forces early exit
Miss 'Stranger Things' already? Here's how you can get your Upside Down fix in 2026 with spinoffs, games and more












